Diagnosing myocardial injury in the high-sensitivity troponin era
Submitted: 18 September 2018
Accepted: 2 October 2018
Published: 10 December 2018
Accepted: 2 October 2018
Abstract Views: 803
PDF: 445
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Giuseppe Lippi, Camilla Mattiuzzi, Gianfranco Cervellin, Biomarker validation in the emergency department. General criteria and clinical implications , Emergency Care Journal: Vol. 10 No. 1 (2014)
- Giuseppe Lippi, Mario Cavazza, Andrea Peracino, Marco Tubaro, Alexandru Nechita, Paola Ballarino, Frank W. Peacock, Salvatore Di Somma, Ischemic heart disease in the emergency room: state of the art, innovation and research , Emergency Care Journal: Vol. 9 No. 1 (2013)
- Elisa Conti, Marcello Guidi, Cavazza Mario, The use of the biomarker “copeptin” for the diagnosis of acute chest pain in the Emergency Department , Emergency Care Journal: Vol. 7 No. 3 (2011)
You may also start an advanced similarity search for this article.